Wall Street mints records after Fed, strong earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Boeing (BA) PT Raised to $215 at Canaccord Genuity on 2Q Report; 'Guidance Raise, Strong Execution'
July 27, 2017 12:06 PM EDTCanaccord Genuity raised its price target on Boeing (NYSE: BA) to $215.00 (from $200.00) while maintaining a Hold rating, following the company's second quarter earnings report.
Analyst Ken Herbert notes the company delivered second quarter earnings per share results above consensus projections fueled by... More
McDonald's (MCD) PT Raised to $160 at UBS
July 26, 2017 9:00 AM EDTUBS raised its price target on McDonald's (NYSE: MCD) to $160.00 (from $143.00) while maintaining a Neutral rating following the company's 2Q earnings report. MCD reported 2Q EPS of $1.70, ahead of the consensus estimate of $1.62.
UBS raised 2017 EPS estimates to $6.58. 2018 estimates were also raised to... More
Amgen (AMGN) PT Raised to $180 at UBS Following Solid 2Q
July 26, 2017 8:34 AM EDTUBS raised its price target on Amgen (NASDAQ: AMGN) to $180.00 (from $175.00) while maintaining a Neutral rating. 2Q results were better than expectations with a $145M top-line beat. EPS also beat consensus estimates by $0.18.
UBS increased 2017 Enbrel sales estimates to $5.38B from $5B... More
Akamai Technologies (AKAM) PT Lowered to $54 at RBC Capital; Reiterates Sector Perform
July 26, 2017 8:04 AM EDTRBC Capital lowered its price target on Akamai Technologies (NASDAQ: AKAM) to $54.00 (from $58.00) while maintaining a Sector Perform rating following the company's 2Q. Revenue of $609MM came in above the Street's estimates of $605, with upside coming from the Media Delivery segment.
Q3 Revenue and... More
Akamai Technologies (AKAM) PT Lowered to $48 at Morgan Stanley
July 26, 2017 7:57 AM EDTMorgan Stanley lowered its price target on Akamai Technologies (NASDAQ: AKAM) to $48.00 (from $52.00) while maintaining a Underweight rating.
... More


